NURS FPX 8010 Assessment 4 Quality Improvement Proposal
NURS FPX 8010 Assessment 4 Quality Improvement Proposal Name Capella university NURS-FPX 8010 Executive Leadership in Contemporary Nursing Prof. Name Date Quality Improvement Proposal Slide 1: Welcome, everyone. I am Felicia Chukes. Thank you for joining this discussion on advancing healthcare excellence through quality improvement initiatives. Today, we will explore how the Mayo Clinic’s Department of Medicine aligns its efforts with the strategic priority of delivering superior patient-centered care to achieve impactful outcomes. Slide 2: The Quality Improvement (QI) initiative aims to improve patient care through the organization’s strategic priority of providing highly quality patient-centered care in the Department of Medicine at Mayo Clinic. The Mayo Clinic, the world’s premier center for healthcare, points out that healthcare solutions must adopt applications and tailored cures for every patient. This vision is about developing new treatments and technologies, streamlining the process of testing them, and building a strong, diverse team of researchers to keep advancing healthcare in the future (Caine et al., 2022). This program will enhance care coordination and ensure patients get quality care at any point in their healthcare continuum. Through achieving this strategic plan, the Department of Medicine amplifies its dedication to offering the best quality and personalized healthcare, especially in what the patients are experiencing. Rationale for Establishing the Strategic Priority Slide 3: The strategic priority in the Department of Medicine of Mayo Clinic has been improving patient satisfaction and health outcomes tied to changing healthcare demands from the patients’ perspective. Consumer involvement has been identified in the evidence-based practice literature as a primary practice in delivering quality health services. Other researchers stress that patient-centeredness has better outcomes regarding clinical results, decreasing reaction rates, and satisfaction levels, as these plans are oriented to paying attention to patients’ needs, communicating, and making decisions together (Levitan & Schoenbaum, 2021). The implications of this priority are multifaceted. The coordination mechanism means that the Department of Medicine helps achieve timely and efficient patient care throughout the cycle. It also allows the patients and providers to build a good working relationship since they trust their providers, leading to effective treatment plans and healthier lives (Engle et al., 2021). Fostering a strong, diverse team of researchers is an excellent QI approach because it promotes innovation and inclusivity in addressing complex healthcare challenges. Diverse teams bring varied perspectives and expertise, which enhances problem-solving and the development of creative, patient-centered solutions (Brewster et al., 2021). On the other hand, the lack of individual-centered care priority may lead to the division of care, patient dissatisfaction, and increased healthcare costs. As such, complications and readmissions can be avoided. In pursuit of this priority, Mayo Clinic establishes itself as an institution that embraces advanced solutions like research on cures and technologies to maintain a vanguard of leadership in personalized healthcare. It responds to future health needs but never deviates from focusing on every patient’s needs and wishes. SWOT Analysis for Chosen Strategic Priority Slide 4: Strengths: The Department of Medicine is robustly involved with the Mayo Clinic 2030 strategic plan focusing on patient-centered opportunities in devices and drug development, clinical research, and professional competencies. This aligns with the strategic directions that concentrate on offering excellent cardinal patient care through innovative solutions emanating from patients’ needs to enhance the quality of health care locally and globally (Caine et al., 2022). What has been most appealing to me is that by building on Mayo Clinic’s research and business development experiences, the department has an advantageous opportunity to promote developments in clinical trials and early-phase drug development. This facilitates the bringing out new treatment procedures to enhance clients’ treatment outcomes. This focus is applied to the department’s clinical trials, especially early-phase investigator-initiated trials, ensuring that new effective treatments are developed and made available to patients in the shortest time possible to meet the strategic imperative of delivering superior patient care. Propelled by patient needs, the department creates advanced treatments and technologies, thus supporting Mayo Clinic’s local and global strategic priorities, focusing on improving patient outcomes and satisfaction. The QI initiative promotes the mission of ‘Putting patients first,’ directly strengthening the clinical care delivery system through patient-oriented and integrated research and development. Weaknesses: The Department of Medicine has high resource needs. Delivering integrated teams for devices and drugs alongside clinical trial support may cause resource strain, leading to ineffective patient care. It is due to either waiting time for testing or innovation to implementation discrepancies in certain subspecialties. The ambitious intention in designing a centralized organizational structure might lead the department to complicate the coordination of teamwork with other integrated departments, hence delayed or constrained models of treatment delivery to patients. That is why the departments’ focus on innovation and research might be seen as the focus on aspects that are not always directly related to patients’ needs. Notwithstanding the innovations, sustaining patient-focused care could be difficult when those innovations are still in their experimental state or phase. Opportunities: Telemedicine and remote diagnostics are among the possibilities that the cooperation with the Mayo Clinic Platform opens. This is particularly worth it, especially under a patient-centered care system, since it might enhance patient reach to care, especially in difficult or underserved areas. Diversity in research talents allows the department to source for and adopt different approaches to improve the discovery and subsequent application of more effective patient-centered solutions, which would benefit the cross-sectional, diverse patient population (Pel et al., 2021). Building on existing collaborations with pharmaceutical and biotechnology companies and artificial intelligence (AI) research and development (R&D), the department can advance the speed with which discoveries get translated to patients, directly impacting patient care and elevating the department’s status as a research powerhouse. In the Mayo Clinic’s political landscape, the Department of Medicine’s focus on partnerships with federal agencies, industry leaders, and venture capitalists aligns with broader healthcare policies and funding regulations (Caine et al., 2022). This strategic collaboration ensures sustained financial support and compliance with regulatory standards, enhancing long-term research and patient care initiatives. Threats: Flexibilities in healthcare policy and financing from Federal agencies